The 17q12 copy number variation syndrome refers to copy number variations (CNV) occurring in the chromosome 17q12 region, which may affect the expression of multiple genes in this region, including ERBB2 (HER2), a known therapeutic target for breast cancer (158). This evidence concerns the gene ERBB2 and breast cancer.